Sleep Apnea's Growth Engine Hits a Snag ResMed Inc. 's recent financials paint a rosy picture, with revenue growth driven by its robust product portfolio, led by the AirSense platform.
However, beneath this facade lies a more complex reality: the return of Philips Respironics to the US market looms large as a potential game changer.
The global obstructive sleep apnea (OSA) treatment market is experiencing unprecedented growth, fueled in part by increased awareness and penetration.